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Abstract
Roots and stem-bark of Mahonia aquifolium (Oregon grape) (Berberidaceae) are effectively used in
the treatment of skin inflammatory conditions.
In the present study, the effect of Mahonia aquifolium crude extract and its two representative
alkaloid fractions containing protoberberine and bisbenzylisoquinoline (BBIQ) alkaloids on activity
of 12-lipoxygenase (12-LOX), was studied. The reactivity with 1,1-diphenyl-2-picryl-hydrazyl
(DPPH), a free stable radical, was evaluated to elucidate the rate of possible lipid-derived radical
scavenging in the mechanism of the enzyme inhibition.
The results indicate that although the direct radical scavenging mechanism cannot be ruled out in
the lipoxygenase inhibition by Mahonia aquifolium and its constituents, other mechanisms based on
specific interaction between enzyme and alkaloids could play the critical role in the lipoxygenase
inhibition rather than non-specific reactivity with free radicals.
Background
Mahonia root and stem bark have long been considered to
have anti-inflammatory, anti-bacterial, anti-fungal activ-
ity and they are used particularly for treatment of skin dis-
eases [1-4]. They are indicated for treatment of the
eczema, psoriasis, and other skin conditions [5].
Alkaloids representing the main compounds in Mahonia
aquifolium, belong to two major classes: the protoberber-
ines and the bisbenzylisoquinolines (BBIQ). Through
bioassay-guided fractionation, protoberberine alkaloids,
such as berberine and jatrorrhizine, were isolated as the
main active alkaloids responsible for the relevant effects
in numerous studies conducted so far [6-8]. In particular,
the berberine was reported to exhibit a range of pharma-
cological and biological activities, and interest has been
focused on its antioxidative potential. Berberine was
found to inhibit the single-strand cleveage of DNA [9]. It
did exhibit a strong superoxide anion radical quenching
ability rather than a strong hydroxyl radical scavenging
activity [9]. It was reported to exert a protective effect
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against ONOO-, NO., and O2 
.-, induced oxidative damage
in vitro and to increase cell viability [10].
BBIQ alkaloids, such as berbamine, oxyacanthine, tetran-
drine, have been reported to inhibit platelet activation,
histamine release, superoxide generation by polymorpho-
nuclear leucocytes (PMNL), lipid peroxidation in some
bio-membranes and suppress selectively receptor-medi-
ated phospholipase A2 activation, leading to the produc-
tion of chemical mediators such as prostanoids and
leukotrienes, arachidonic acid metabolites [11,12].
Lipoxygenases (LOXs) comprise a family of non-heme
iron-containing dioxygenases, representing the key
enzymes in the biosynthesis of leukotrienes that have
been postulated to play an important role in the patho-
physiology of several inflammatory and allergic diseases.
The products of LOXs catalysed oxygenation (hydroperox-
yeicosatetraenoic acids (HPETE), hydroxyeicosatetraenoic
acids (HETE), leukotrienes and lipoxins) apparently are
involved in the development of rheumatoid arthritis, pso-
riasis, asthmatic responses and glomerular nephritis [13].
In our study, the Mahonia crude stem bark extract and its
fractions identified as tertiary phenolic BBIQ alkaloids
(fraction I) and quaternary protoberberine alkaloids (frac-
tion II) were assessed for their effect on the activity of 12-
lipoxygenase (12-LOX), isolated from rat lung cytosolic
fraction. Since the mechanism of the enzyme inhibition
may include reduction of lipidperoxy- or lipidoxy-radi-
cals, the effects of the samples tested on the 12-LOX activ-
ity were compared with their abilities to scavenge 1,1-
diphenyl-2-picryl-hydrazyl (DPPH), a free stable radical.
Two alkaloids (berberine and jatrorrhizine) isolated from
fraction II were used as the standards in the in vitro assays.
Methods
Chemicals
α,α'-diphenyl-β-picrylhydrazyl (DPPH) radicals were
obtained from Sigma Chemical Co. (St Louis, MO, USA).
Linoleic acid (99%, Sigma) was used as a substrate pre-
pared in solubilized state as described [14]. Other chemi-
cals were purchased from local commercial sources and
they were of analytical grade quality.
Preparation and analysis of Mahoniae stem-bark extract
Plant material
The stem-bark of cultivated Mahonia aquifolium was col-
lected in October 2002 from Arboretum Mlynany, Faculty
of Pharmacy, Bratislava. The authentic specimen is depos-
ited in the herbarium at the Department of Pharmacog-
nosy and Botany, Faculty of Pharmacy (No. Ma 108/9).
Extract preparation
Mahonia  stem-bark (Mahonia aquifolium (Pursh) Nutt.)
was finely powdered and macerated with 62% ethanol
(1:10, w/v) for 4 days at room temperature. After removal
of the insoluble matter by filtration, the filtrate was con-
centrated under reduced pressure to yield a dark colored
residue. The residue was then dissolved in 10% HCl and
the yellow precipitate was filtered through filter paper, the
filtrate being concentrated under reduced pressure (fil-
trate: water = 20:1, w/w). The remaining aqueous extract
was crude Mahonia extract.
Fractionation of stem-bark extract Mahoniae
A solution of 25 % NH4OH was added to the remaining
acidified extract so as to adjust its acidity to pH 8–10 and
then it was extracted with diethyl ether (4 × 500 ml). The
combined ether extract was evaporated up to dryness
under reduced pressure and monitored by thin-layer chro-
matography so as to yield 6.80 g fraction I of ether- solu-
ble BBIQ alkaloids fraction. The remaining aqueous
extract was then acidified to pH 4–5 with 10% HCl and KI
solution was added so that a precipitate of quaternary pro-
toberberine alkaloids was obtained. The yellow coloured
precipitate was extracted with CHCl3 (5 × 1000 ml). The
combined chloroform extract was evaporated up to dry-
ness and monitored by thin – layer chromatography,
yielding in 19.9 g of chloroform-soluble quaternary pro-
toberberine alkaloid iodide fraction (fraction II).
The yields of fraction I and II (concentrated under reduced
pressure and then lyophilized to yield a residue) were 8.6
% and 36.8% w/w, respectively.
The filtrate of crude Mahonia extract was concentrated and
then lyophilized to yield a residue. The extract yield was
25.6% of the original material weight.
Isolation of alkaloids from fraction II
Part of the quaternary protoberberine iodides (fraction II)
was adsorbed on to silica gel and subjected to a silica gel
column chromatography, eluted with chloroform, with
the mixtures of chloroform – MeOH (2:1, 1:1. 1:2, 1:4)
and MeOH, each about 200 ml with 6 fractions as a result.
Fractions 2 and 3 were repeatedly chromatographed on
the silica gel column and further purified by recrystaliza-
tion from EtOH to yield the berberine and jatrorrhizine as
iodides.
Structural analysis of isolated alkaloids
The isolated compounds were identified by direct com-
parison to the corresponding authentic samples [15]. The
purity (>95%) of the above compounds was checked by
HPLC analysis [16]. The amount of each alkaloid in the
particular fractions was as follows, phenolic BBIQ alka-
loids (fraction I): baluchistine 0.074% %, aquifolineJournal of Inflammation 2007, 4:15 http://www.journal-inflammation.com/content/4/1/15
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0.071%, oxyacanthine 0.048%, berbamine 0.042%,
obamegine 0.038%, aromoline 0.005%, protoberberine
alkaloids (fraction II): jatrorrhizine 0.146%, berberine
0.112%, palmatine 0.088%, columbamine 0.030% (w/
w).
In vitro experiments
12-lipoxygenase inhibition assay
A cytosolic fraction from rat (Wistar, male 180 g) lungs
representing a source of 12-lipoxygenase was isolated
according to the procedure of Kulkarni et al. [17]. The
experiments with animals were performed in the labora-
tory complying Good Laboratory Practice certificate and
according to the Law of the National Council of Slovak
Republic on the protection of animals No. 115/1995,
Edict of Ministry of Agriculture on the breeding of society
animals, wild animals and dangerous animals and the
protection of laboratory animals No 231/1998 and Coun-
cil Directive 86/609/EEC on the approximation of laws,
regulations and administrative provisions of the Member
States regarding the protection of animals used for exper-
imental and other scientific purposes
A spectrophotometric assay for determination of LOX
activity was used, i.e. the reaction medium (2.0 ml final
volume) contained 50 mM Tris-HCl buffer (pH 8.5), 100
mg of enzyme protein and a solution of linoleic acid pre-
pared in solubilised state [14]. The enzyme inhibitory
effect was tested by adding different volumes of the stock
solution (0.5 mg/ml) of the extract or fractions tested to
the incubation mixture. The pure compounds were tested
in final concentrations 15.106 – 25.10-6 mol/l. The LOX
activity was monitored as an increase of the absorbance at
234 nm what reflects the formation of hydroperoxylino-
leic acid. The extinction coefficient of 25 mM-1. cm-1 was
used for calculation of enzyme activity. The inhibitory
effect of compounds tested was expressed as IC50 and per-
centage of enzyme activity inhibition.
Radical scavenging assay
The free radical scavenging capacity of the compounds
tested, crude extract and fractions was determined by
using DPPH assay [18-20]. The stock solutions of the sam-
ples were prepared in ethanol (0.8 mg/ml for the frac-
tions; 0.47 mg/ml for the standard compounds) and in
water (0.7 mg/ml) as far as the crude extract was con-
cerned.
A total 100 μl sample was mixed with a 2900 μl ethanol
solution of DPPH (final concentration 60 μM), and the
Table 1: Results of lipoxygenase inhibitory effects of crude Mahonia extract and two representative alkaloid fractions tested.
Final concentration (g/L) Activity of lipoxygenase 
(kat)
% Inhibition IC50 (g/L)
Crude Mahonia extract 0.50.10-3 7.40 ± 0.89 43.03 ± 0.54 0.76.10-3 ± 0.12.10-3
0.75.10-3 6.34 ± 7.63 51.19 ± 0.96*
1.25.10-3 5.2 8 ± 0.78 59.32 ± 1.39*
1.88.10-3 3.53 ± 0.34 72.80 ± 1.54*
2.50.10-3 2.92 ± 0.28 78.80 ± 1.72*
Control - 12.99 ± 1.23 -
Fraction I
1.25.10-3 1.16 ± 0.11 16.54 ± 7.67 4.63.10-3 ± 1.03.10-3
2.50.10-3 0.94 ± 0.09 32.23 ± 2.63
3.75.10-3 0.71 ± 0.09 47.33 ± 2.24
5.10-3 0.63 ± 0.07 54.67 ± 1.64*
6.25.10-3 0.55 ± 0.06 60.43 ± 2.36*
7.50.10-3 0.34 ± 0.04 75.39 ± 2.10*
Control - 1.39 ± 0.14 -
Fraction II
1.25.10-3 1.24 ± 0.12 10.93 ± 4.76 6.10.10-3 ± 0.98.10-3
2.50.10-3 1.11 ± 0.10 18.27 ± 6.23
3.75.10-3 0.95 ± 0.09 31.08 ± 2.25
5.10-3 0.87 ± 0.09 39.28 ± 2.47
6.25.10-3 0.64 ± 0.07 53.67 ± 2.33*
7.50.10-3 0.56 ± 0.06 60.86 ± 3.04*
Control - 1.39 ± 0.24 -
Lipoxygenase activity was determined as absorbance increase at λmax = 234 nm at 3 minutes of incubation with or without inhibitor tested. Values 
of hydroperoxide content and lipoxygenase activity were calculated from equation c = A.V/ε.l.v, where A is the value of absorbance increase, V is 
the volume of incubation mixture, ε is the extinction coefficient for linoleic acid (25.10-3 mol.l.cm-1), l is the length of the cuvette (1 cm) and v is the 
volume of enzyme (0.015 ml). Results are presented as percent of control ± SD, n = 3, * p < 0.05 vs. controlsJournal of Inflammation 2007, 4:15 http://www.journal-inflammation.com/content/4/1/15
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reaction proceeded for 5 hours. After the reaction time,
the absorbance change was measured at 515 nm by
Hewlett-Packard Diode Array Spectrophotometer 8452A
spectrophotometer. Measurements were performed at
least triplicate. The standard curves for the reaction of
Trolox with DPPH and the readings were then used for
calculation of the total antioxidant capacity (TAC) of the
sample tested, expressed in μg Trolox equivalents/g [21].
Statistical analysis
Each experiment was performed in triplicate. Results are
expressed as the means ± S.D. Statistical analysis was per-
formed using unpaired Student's t-test using X-Plot v. 2.81
and statistical significance is expressed as *, p < 0.05.
Results
Lipoxygenase inhibitory effect
The LOX activity (12-arachidonate LOX purified from rat
lung cytosol fraction) was monitored as an increase in the
absorbance at 234 nm, which reflects the formation of
hydroperoxylinoleic acid. The highest inhibitory effect
was obtained for crude extract of Mahonia aquifolium (IC50
= 0.76.10-3 ± 0.12.10-3 g/L) (Table 1). As far as the two
alkaloid fractions were compared, a higher inhibition of
LOX is caused by fraction I (IC50 = 4.63.10-3 ± 1.03.10-3 g/
L) than by fraction II (IC50 = 6.10.10-3 ± 0.98.10-3 g/L).
IC50 values, determined for the isolated compounds, were
30.5.10-6 ± 2.87.10-6 mol/l (berberine) and 17.5.10-6 ±
1.27.10-6 mol/l (jatrorrhizine) (Table 2).
Radical scavenging activity
In order to assess the radical scavenging potential of the
crude extract, fractions I, II and the compounds isolated,
the reactivity towards the stable free radical DPPH was
measured at 518 nm by measurement of absorbance
decrease of the reaction mixture after 5 hour-reaction
time. The results expressed as TAC in μg Trolox equiva-
lents/g (Table 3) [21] showed that the most potent anti-
radical reactivity may be attributed to the phenolic BBIQ
alkaloids constituting fraction I, whereas a remarkably
lower antioxidant capacity was obtained for the samples
of crude extract, fraction II and berberine with compara-
ble values of TAC. Jatrorrhizine, the phenolic alkaloid,
showed a significantly higher antiradical activity than ber-
berine, the other standard used.
Discussion
This study elucidates the possible contribution of the rad-
ical scavenging effect to the lipoxygenase inhibitory mech-
anism of the crude Mahonia aquifolium extract and two
isolated alkaloid fractions, containing phenolic BBIQ
alkaloids (fraction I) and protoberberine alkaloids (frac-
tion II). Two representative alkaloids, jatrorrhizine, pos-
sessing phenolic moiety and its non-hydroxylated
analogue, berberine, were isolated from fraction II and
used in the assays of the antiradical and anti-lipoxygenase
activity as standards.
LOXs are the family of the key enzyme in the biosynthesis
of leukotrienes that are postulated to play an important
role in the pathophysiology of several inflammatory dis-
seases. According to the currently used nomenclature, the
LOXs are classified with respect to their positional specif-
icity of arachidonic acid oxygenation (5-LOX, 9-LOX, 12-
LOX, 15-LOX) [22].
In the present work, the LOX inhibitory properties were
tested on purified arachidonate-12-LOX from rat lung
cytosol fraction. 12-LOX metabolites of arachidonic acid
are potent mediators of inflammation and one of the reg-
ulators of pulmonary vascular tone, and their production
is increased during lungs vascular injury [23]. 12-lipoxy-
Table 2: Results of lipoxygenase inhibitory effects of two representative alkaloids isolated from Mahonia aq. crude extract.
Final concentration (mol/l) Activity of lipoxygenase % Inhibition IC50 (mol/L)
Aqueous solution of 
jatrorrhizine (0.01M)
15.10-6 118.71 ± 4.37 22.05 ± 1.37 17.50.10-6 ± 1.27.10-6
20.10-6 23.89 ± 1.83 84.32 ± 3.74*
25.10-6 12.73 ± 1.24 91.58 ± 2.91*
Control - 152.29 ± 5.37 -
Aqueous solution of 
berberine (0.01M)
15.10-6 233.19 ± 7.41 14.88 ± 0.97 30.50.10-6 ± 2.87.10-6
20.10-6 213.40 ± 6.93 22.11± 1.24
25.10-6 157.02 ± 4.21 42.69 ± 2.38
Control - 273.96 ± 8.21 -
Lipoxygenase activity was determined as absorbance increase at λmax = 234 nm at 3 minutes of incubation with or without inhibitor tested. Values 
of hydroperoxide content and lipoxygenase activity were calculated from equation c = A.V/ε.l.v, where A is the value of absorbance increase, V is 
the volume of incubation mixture, ε is the extinction coefficient for linolic acid (25.10-3 mol.l.cm-1), l is the length of the cuvette (1 cm) and v is the 
volume of enzyme (0.015 ml). Results are presented as percent of control ± SD, n = 3, * p < 0.05 vs. controlsJournal of Inflammation 2007, 4:15 http://www.journal-inflammation.com/content/4/1/15
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genase products (12-HETE) are also potent mediators of
cutaneous inflammation. These eicosanoids have been
found in biologically active amounts in scales and sam-
ples of lesional psoriatic skin [1].
LOX are sensitive to antioxidants, and the most common
way of their action may consist in inhibition of lipid
hydroperoxide formation due to scavenging of lipidoxy-
or lipidperoxy-radicals formed in course of enzymic per-
oxidation. This can limit the availability of lipid hydroper-
oxide substrate necessary for the catalytic cycle of LOX.
An inhibition of the lipoxygenases by antioxidants can be
also attained via chelation of its non-heme bound iron
[24] or by reduction of its ferric form [25-27], suggesting
a competitive kind of inhibition. However, non-competi-
titve or mixed competitive/non-competitive inhibition of
LOX was also shown for tocopherol acetate or β-carotene,
respectively [28].
In our previous studies, an LOX inhibition potential was
obtained for series of the BBIQ alkaloids [16], as well as
the protoberberine and aporphine alkaloids [29] and the
values of enzyme inhibition showed a strong linear corre-
lation with the antiperoxidant effects of the compounds
tested. These results indicated that the mechanism of the
LOX inhibition effect could be partly explained by direct
reduction of peroxy- and alkoxy-radicals.
However, a simpler assay system is required to elucidate
the role of a direct free radical scavenging in the lipoxyge-
nase inhibition by Mahonia aquifolium alkaloids, since in
the previously used liposomal model of lipid peroxida-
tion (induced by the Fenton system), the resulting effect
may be considered as a superimposition of reactivity of
the compounds with free radicals, chelation of Fe2+ or par-
tition process in the heterogeneous membrane system.
For this reasons, we evaluated the consistency of anti-
lipoxygenase activity of the samples tested with their reac-
tivity with DPPH, a free radical model. DPPH is also con-
sidered as a good kinetic model for peroxyl radicals [18-
20].
In order to put the common parameter for comparison of
the antiradical activity of the fractions and the crude
extract with the pure compounds, we have evaluated the
total antioxidant activity (TAC) [21] of the samples tested.
In consistency with our previous results [30], the highest
value of TAC was obtained for fraction I containing bis-
benzylisoquinoline (BBIQ) alkaloids (baluchistine, aqui-
foline oxyacanthine, berbamine, obamegine, aromoline),
possessing properties of phenolic antioxidants (Table 3).
The crude extract and fraction II (containing protoberber-
ine alkaloids with reduced number of free OH moieties)
showed a remarkably lower and comparable antiradical
activity. Contrary to the previously obtained results for
lipid peroxidation and lipoxygenase inhibition assay
[17,29], we obtained a remarkably low antiradical activity
for the Mahonia crude extract.
As shown in Table 1, the strongest lipoxygenase inhibition
was obtained for the crude extract (IC50 = 0.76.10-3 ±
0.12.10-3g/L). Although, analogously to TAC values, phe-
nolic BBIQ fraction I showed the stronger LOX inhibition
effect (IC50 = 4.63 ± 1.03.10-3gL) than protoberberine
alkaloid fraction II (IC50 = 6.1.10-3 ± 0.98.10-3g/L), the dif-
ference between their enzyme inhibition activities was not
so remarkable as that between their antiradical activities.
These results suggest that a scavenging effect may not be a
critical factor behind the inhibition of LOX by the crude
Mahonia extract and its two fractions and the inhibitory
effects are possibly due to specific interaction of the con-
stituents with the enzyme. As mentioned above, an inter-
action with iron atom at the enzyme catalytic centre may
be involved in the LOX inhibition mechanism. Regarding
catecholic type of structures of Mahonia aquifolium constit-
uents, the LOX activity could be abolished via formation
of stable chelates of its non-heme iron, as it has been
shown for aporphine alkaloid, apomorphine [31], sug-
Table 3: TAC of Mahonia crude extract, fraction Iand II and two representative alkaloids.
TAC, μg Trolox equiv/g
Fraction I 209 833.3 ± 4880.0
Fraction II 39 969.7 ± 3007.3
Mahonia crude extract 71 406.8 ± 5822.6
Jatrorrhizine 116 519.5 ± 1601.4
Berberine 38 441.6 ± 3171.3
A total 100 μl sample was mixed with a 2900 μl ethanol solution of DPPH (final concentration 60 μM), and the reaction continued for 5 hours. The 
final concentrations in the reaction mixture of the samples tested were as follows: 0.027 mg/ml for the fractions; 0.016 mg/ml for the standard 
compounds and 0.023 mg/ml for crude extract in water. Total antioxidant capacity (TAC) was calculated using standard curves for the reaction of 
Trolox with DPPH and the absorbance change at 515 nm after the reaction time, and the readings were then used to calculate TAC in the sample, 
expressed in μg Trolox equivalents/g. Each result is expressed as mean ± S.D. for three values.Journal of Inflammation 2007, 4:15 http://www.journal-inflammation.com/content/4/1/15
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gesting thus a competitive mode of enzyme inhibition.
This could also explain the good correlation between LOX
inhibition effects of the Mahonia extract and its constitu-
ents and their protective effects against lipid peroxidation
[17,29], exerted probably via interaction with Fe2+ of the
initiator system (FeSO4/H2O2). However, regarding the
size of BBIQ molecules, other types of inhibition involv-
ing preferential interaction with other than enzyme's cat-
alytic cavity (i.e. allosteric, uncompetitive or non-
competitive inhibition), cannot be excluded.
Expectably, a hydroxylated alkaloid jatrorrhizine showed
three times higher antiradical reactivity expressed as TAC
than its non-hydroxylated analogue, berberine (Table 3).
The radical scavenging properties related to OH moiety on
the alkaloid skeleton of jatrorrhizine may be also respon-
sible for the increase of enzyme inhibitory effect (IC50 =
17.5.10-6 ± 1.27.10-6 mol/L, Table 2) in comparison to
berberine (IC50 = 30.5.10-6 ± 2.87.10-6 mol/L), as indi-
cated by the consistency with results of DPPH radical scav-
enging assay.
In conclusion, our results indicate that although the direct
scavenging of free radicals cannot be ruled out in the
mechanism of lipoxygenase inhibition by the Mahonia
aquifolium extract and its two representative fractions con-
taining BBIQ and protoberberine alkaloids, this does not
seem to be the critical mechanism through which Mahonia
aquifolium and its constituents exert their inhibition
effects and these can be rather explained by a direct spe-
cific interaction of the constituents with LOX enzyme.
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